Free Trial

Santen Pharmaceutical (SNPHY) Short Interest Ratio & Short Volume

$10.89 +1.01 (+10.22%)
(As of 11/21/2024 ET)

Santen Pharmaceutical Short Interest Data

Santen Pharmaceutical (SNPHY) has a short interest of 100 shares. This marks a -85.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 6,391 shares to cover all short positions.

Current Short Interest
100 shares
Previous Short Interest
700 shares
Change Vs. Previous Month
-85.71%
Dollar Volume Sold Short
$1,184.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Today's Trading Volume
5,531 shares
Average Trading Volume
6,391 shares
Today's Volume Vs. Average
87%
Short Selling Santen Pharmaceutical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Santen Pharmaceutical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SNPHY Short Interest Over Time

SNPHY Days to Cover Over Time

SNPHY Percentage of Float Shorted Over Time

Santen Pharmaceutical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024100 shares $1,184.00 -85.7%N/A0 $11.84
10/15/2024700 shares $8,442.00 -12.5%N/A0.3 $12.06
9/30/2024800 shares $10,124.00 -57.9%N/A0.1 $12.66
9/15/20241,900 shares $24,348.50 -17.4%N/A0.5 $12.82
8/31/20242,300 shares $28,508.50 +4.6%N/A1 $12.40
8/15/20242,200 shares $26,554.00 +15.8%N/A0.1 $12.07
7/31/20241,900 shares $22,325.00 -24.0%N/A0 $11.75
7/15/20242,500 shares $28,175.00 -3.9%N/A1.9 $11.27
6/30/20242,600 shares $26,520.00 -10.3%N/A0.2 $10.20
6/15/20242,900 shares $29,717.75 +383.3%N/A0.8 $10.25
5/31/2024600 shares $6,160.20 No ChangeN/A0.3 $10.27
4/30/2024100 shares $994.00 No ChangeN/A0 $9.94
4/15/2024100 shares $912.00 No ChangeN/A0 $9.12
3/31/2024100 shares $975.00 No ChangeN/A0.1 $9.75
3/15/2024100 shares $982.42 -99.5%N/A0 $9.82
2/29/202420,800 shares $204,464.00 +20,700.0%N/A0.7 $9.83
2/15/2024100 shares $1,001.00 No ChangeN/A0 $10.01
1/15/2024100 shares $1,014.00 No ChangeN/A0.1 $10.14
11/30/2023900 shares $8,595.45 +80.0%N/A0.4 $9.55
11/15/2023500 shares $4,490.00 +400.0%N/A0.1 $8.98
10/31/2023100 shares $868.50 -85.7%N/A0 $8.69
10/15/2023700 shares $6,204.45 -41.7%N/A0.3 $8.86
9/30/20231,200 shares $10,944.00 -64.7%N/A0.3 $9.12
9/15/20233,400 shares $32,878.00 -30.6%N/A2.1 $9.67
8/31/20234,900 shares $45,300.50 +36.1%N/A1.5 $9.25
8/15/20233,600 shares $33,588.00 -52.6%N/A0.4 $9.33
7/31/20237,600 shares $65,664.00 +216.7%N/A1.4 $8.64
7/15/20232,400 shares $20,040.00 +242.9%N/A0.3 $8.35
6/30/2023700 shares $5,908.00 +16.7%N/A0 $8.44
6/15/2023600 shares $5,100.00 +100.0%N/A0.1 $8.50
5/31/2023300 shares $2,742.00 -25.0%N/A0.2 $9.14
5/15/2023400 shares $3,624.00 No ChangeN/A0.2 $9.06
4/15/2023400 shares $3,296.00 +100.0%N/A0.1 $8.24
3/31/2023200 shares $1,694.00 -60.0%N/A0 $8.47
3/15/2023500 shares $3,810.00 No ChangeN/A0.1 $7.62
2/15/2023100 shares $739.00 -90.0%N/A0 $7.39
1/31/20231,000 shares $7,710.00 No ChangeN/A0.2 $7.71
12/30/2022700 shares $5,624.50 -58.8%N/A0.1 $8.04
12/15/20221,700 shares $13,642.50 -74.6%N/A0.2 $8.03
11/30/20226,700 shares $53,600.00 +86.1%N/A0.4 $8.00
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

11/15/20223,600 shares $27,468.00 +12.5%N/A0.1 $7.63
10/31/20223,200 shares $21,840.00 -94.0%N/A0.1 $6.83
10/15/202253,100 shares $348,336.00 +517.4%N/A0.9 $6.56
9/30/20228,600 shares $58,222.00 +207.1%N/A0.1 $6.77
9/15/20222,800 shares $18,760.00 -85.6%N/A0 $6.70
8/31/202219,500 shares $139,230.00 +236.2%N/A0.3 $7.14
8/15/20225,800 shares $45,396.60 +5,700.0%N/A0.2 $7.83
7/31/2022100 shares $801.50 No ChangeN/A0 $8.02
6/15/2022400 shares $2,916.00 -90.9%N/A0 $7.29
5/31/20224,400 shares $35,310.00 -63.3%N/A0 $8.03
5/15/202212,000 shares $95,520.00 +823.1%N/A0 $7.96
4/30/20221,300 shares $10,517.00 -38.1%N/A0 $8.09
4/15/20222,100 shares $18,270.00 -92.0%N/A0 $8.70
3/31/202226,300 shares $262,474.00 +87.9%N/A0.3 $9.98
3/15/202214,000 shares $152,600.00 -8.5%N/A0.1 $10.90
2/28/202215,300 shares $173,349.00 -26.4%N/A0.1 $11.33
2/15/202220,800 shares $236,496.00 +300.0%N/A0.1 $11.37
1/31/20225,200 shares $58,812.00 +1,200.0%N/A0 $11.31
1/15/2022400 shares $4,864.00 -98.2%N/A0 $12.16
12/31/202121,600 shares $262,980.00 No ChangeN/A0.1 $12.18
11/30/20211,800 shares $23,670.00 -85.9%N/A0 $13.15
11/15/202112,800 shares $178,412.80 +17.4%N/A0.3 $13.94
10/29/202110,900 shares $153,690.00 +10,800.0%N/A0.2 $14.10
10/15/2021100 shares $1,378.00 -98.4%N/A0 $13.78
9/30/20216,400 shares $90,016.00 +52.4%N/A0.2 $14.07
9/15/20214,200 shares $63,798.00 -8.7%N/A0.2 $15.19
8/31/20214,600 shares $69,368.00 -82.4%N/A0 $15.08
8/13/202126,100 shares $389,673.00 -29.3%N/A0.5 $14.93
7/30/202136,900 shares $498,519.00 +738.6%N/A0.6 $13.51
7/15/20214,400 shares $61,908.00 -85.7%N/A0.1 $14.07
6/30/202130,800 shares $425,964.00 -18.5%N/A0.5 $13.83
6/15/202137,800 shares $526,176.00 +384.6%N/A0.3 $13.92
5/28/20217,800 shares $103,896.00 +136.4%N/A0.1 $13.32
5/14/20213,300 shares $44,253.00 -89.2%N/A0 $13.41
4/30/202130,500 shares $393,145.00 -12.6%N/A0.3 $12.89
4/15/202134,900 shares $466,613.00 -44.4%N/A0.2 $13.37
3/31/202162,800 shares $869,780.00 +784.5%N/A0.5 $13.85
3/15/20217,100 shares $96,986.00 -27.6%N/A0.1 $13.66
2/26/20219,800 shares $137,788.00 +38.0%N/A0.1 $14.06
2/12/20217,100 shares $111,399.00 -70.7%N/A0.1 $15.69
1/29/202124,200 shares $400,026.00 +414.9%N/A0.5 $16.53
12/31/202013,200 shares $213,048.00 No ChangeN/A0.2 $16.14
11/30/20203,800 shares $64,284.60 -85.7%N/A0.1 $16.92
11/15/202026,600 shares $434,577.50 +786.7%N/A0.6 $16.34
10/30/20203,000 shares $55,530.00 +66.7%N/A0.2 $18.51
10/15/20201,800 shares $35,928.00 -86.4%N/A0 $19.96
9/30/202013,200 shares $271,260.00 -5.7%N/A1.1 $20.55
9/15/202014,000 shares $276,220.00 +225.6%N/A0.5 $19.73
8/31/20204,300 shares $81,958.00 -76.5%N/A0.2 $19.06
8/14/202018,300 shares $342,235.62 +16.6%N/A0.5 $18.70
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
7/31/202015,700 shares $263,775.70 +31.9%N/A0.5 $16.80
7/15/202011,900 shares $212,534.00 -25.6%N/A0.5 $17.86
6/30/202016,000 shares $294,720.00 +233.3%N/A0.7 $18.42
6/15/20204,800 shares $89,205.60 -65.0%N/A0.2 $18.58
5/29/202013,700 shares $252,011.50 -22.6%N/A0.4 $18.40
5/15/202017,700 shares $313,520.10 +88.3%N/A0.4 $17.71
4/30/20209,400 shares $165,534.00 -40.1%N/A0.1 $17.61
4/15/202015,700 shares $273,337.00 -50.2%N/A0.3 $17.41
3/31/202031,500 shares $535,185.00 +416.4%N/A0.4 $16.99
3/13/20206,100 shares $84,790.00 -72.3%N/A0.1 $13.90
2/28/202022,000 shares $352,660.00 +168.3%N/A0.4 $16.03
2/14/20208,200 shares $130,380.00 -48.4%N/A0.2 $15.90
1/31/202015,900 shares $297,648.00 +169.5%N/A1.5 $18.72
1/15/20205,900 shares $115,728.50 +156.5%N/A0.7 $19.62
12/31/20192,300 shares $44,689.00 +27.8%N/A0.2 $19.43

SNPHY Short Interest - Frequently Asked Questions

What is Santen Pharmaceutical's current short interest?

Short interest is the volume of Santen Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 100 shares of SNPHY short. Learn More on Santen Pharmaceutical's current short interest.

Is Santen Pharmaceutical's short interest increasing or decreasing?

Santen Pharmaceutical saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 100 shares, a decline of 85.7% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Santen Pharmaceutical stock?

Short selling SNPHY is an investing strategy that aims to generate trading profit from Santen Pharmaceutical as its price is falling. SNPHY shares are trading up $1.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Santen Pharmaceutical?

A short squeeze for Santen Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPHY, which in turn drives the price of the stock up even further.

How often is Santen Pharmaceutical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPHY, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:SNPHY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners